Document Detail


The consequence of secret prices: the politics of physician preference items.
MedLine Citation:
PMID:  18997212     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper assesses the implications for policy of recent aggressive efforts by manufacturers to enforce price-confidentiality clauses in contracts with hospitals for purchases of physician preference items (PPIs) such as implantable medical devices. Secrecy clauses prevent hospitals from revealing prices to third parties that help them negotiate prices and to surgeons who specify which device brands and models hospitals purchase. Litigation focused the attention of journalists and policymakers on problems that result from the asymmetry of information between buyers and sellers in the market for PPIs. Legislation is pending.
Authors:
Jeffrey C Lerner; Daniel M Fox; Todd Nelson; John B Reiss
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Health affairs (Project Hope)     Volume:  27     ISSN:  1544-5208     ISO Abbreviation:  Health Aff (Millwood)     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-11-10     Completed Date:  2009-02-20     Revised Date:  2009-05-06    
Medline Journal Info:
Nlm Unique ID:  8303128     Medline TA:  Health Aff (Millwood)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1560-5     Citation Subset:  IM    
Affiliation:
ECRI Institute in Plymouth Meeting, Pennsylvania, USA. jlerner@ecri.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Commerce*
Coronary Artery Bypass
Cost-Benefit Analysis*
Myocardial Revascularization
Organizational Case Studies
Physicians*
Prostheses and Implants / economics
Quality-Adjusted Life Years
Technology, Medical / economics*
Comments/Corrections
Comment In:
Health Aff (Millwood). 2009 May-Jun;28(3):925; author reply 925   [PMID:  19414913 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The need for greater price transparency in the medical device industry: an economic analysis.
Next Document:  Diffusion of new technology and payment policies: coronary stents.